Condition: Functional Mitral Regurgitation · Sponsor: Bio Refine Ltd.
The purpose of this study is to evaluate the safety and feasibility of the Bio Refine Coriofix System and determine if it might help in treatment of functional mitral regurgitation. The study will include patients with symptomatic secondary mitral regurgitation in whom mitral surgery cannot and/or will not be offered as a treatment option (the risk is prohibitive). Potential patients will be screened to confirm that all inclusion/exclusion criteria are met, with final eligibility confirmation on day of procedure. All enrolled subjects who went through the procedure will be followed during the procedure to hospital discharge. Additional follow up time points are scheduled at 30 days, 6 months and 12 months post procedure.
This description comes directly from the study's public registry record.
Boaz Shenhav · 972-52-561-1151 · boaz.s@bio-refine.com
Always discuss trial participation with your own doctor first.
| Gottsegen National Cardiovascular Center | Budapest, Hungary | Recruiting |
| Rabin Medical Center | Petah Tikva, Israel | Recruiting |
| Institute for Cardiovascular Diseases "Dedinje" | Belgrade, Serbia | Recruiting |
| University Clinical Center Kragujevac | Kragujevac, Serbia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06583876